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Diabetes mellitus, DM, is commonly accompanied with various stages of hemorheologic disturbances
that are the main causes of the development of chronic DM. In this study, simple Chinese material
medica [yang-yin jiang-tang preparation (YYJT)] was given to alloxan-induced DM rats and analyzed to
compare the changes of fasting blood glucose (FBG), fasting insulin (FINS), hemorheologic parameters
and insulin-like growth factor II (IGF-II) before and after administration. The results suggested that
YYJT can significantly downregulate FBG (P < 0.005), improve insulin resistance and beta-cell
secretion (P < 0.05), decrease whole blood viscosity at low and high shear rates, gathering of blood
index test (GIT) and fibrinogen (FIB) (P < 0.05), and enlarge the function of IGF-II (P < 0.05). We
concluded that YYJT could prevent and treat hemorheologic disorder in DM rats by means of reducing
glucose, improving insulin resistance and elevating IGF-II.
Keywords: Chinese material medica – diabetes mellitus rat – hemorheology – insulin resistance –
insulin secretion – insulin-like growth factor II
Introduction
Patients with diabetes mellitus (DM) usually develop a range
of hemorheologic disturbances due to glucolipotoxicity.
Angiopathy is a risk factor of chronic DM complications
(1,2). Widespread research is currently taking place in China
and other countries to explore new traditional Chinese
medicine and Western medicine that will improve hypervisc-
osity syndrome and prevent and treat chronic complications
of DM (3,4). In traditional medical theory, DM is in the
concept of ‘xiao-ke’ with deficiency of Yin and dryness-heat,
where the in vivo blocks of blood gore leads to hemorheologic
disorder. Therefore, reinforcing Qi, nourishing Yin, removing
blood stasis and promoting blood circulation is the principle
of DM treatment in traditional medicine (5–7). The
administration of simple Chinese material medica not only
has hypoglycemic effect but also improves hyperviscosity
syndrome in DM, which are the advantages in the treatment of
DM with TCM. Against the above background, in this study,
simple Chinese material medica [yang-yin jiang-tang prepara-
tion (YYJT)], which can nourish Yin and promote blood
circulation, was used in DM rats to investigate its mechanism
and clinical value for improving hemorheologic disorder.
Methods
Rats
Male Sprague-Dawley rats, about 3 months old, were obtained
from the Animal Center, Zhejiang Academy of Medical
Science, SCXK (Shanghai, manufacture permission number
2003-0003). All rats were randomly divided into a control
group, an experimental group and a YYJT-treated group,
consisting 12 rats each.
Reagent
Alloxan (A-7413,Lot-36H0102) was supplied by Sigma com-
pany, Insulin radioimmunoassay reagent box (lot: 2008-10236)
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China, POD-PAD reagent box (lot: 03174) by the experi-
mental center of clinical diagnostic reagent, China National
Biotec Corporation, rat IGF reagent box (lot: 0305) by General
Hospital of PLA and Yangyinjiangtangpian (YYJT, lot:
ZZ-2970-037801) by Chiatai Qingchun Bao Pharmaceutical
Co., Ltd, China.
Apparatus
We used Intelligent Radioimmuno instrument model SN-695
made by the Shanghai Research Institute of atomic nucleus,
Revolving Blood Viscosity calculator LBY-N6A and NM1
models, by Beijing Plant of Medical Devices, and ACL-200
instrument, by Beckman Coulter, USA.
Animal Model
The control group was allowed free access to food and water,
the other two groups were fasted for 24 h before establishing
the model. Sublingual intravenous injections of Alloxan
(50 mg kg
 1) were given under anesthesia induced by sodium
pentobarbital (40 mg kg
 1) and the DM models were
established 72 h later (8–10). The rats that had levels of
glucose above 300 mg dl
 1 for 3 days were randomly divided
into the experimental (12 rats) and YYJT-treated (12 rats)
groups.
Administration
The control group had free access to food and water. The
experimental groups were drenched once a day via the stomach
with equal amounts of normal saline solution. The YYJT-
treated group was perfused via the stomach with a suspension
from crude drug (4.66 g kg
 1), once a day. The animals were
kept in stable clean conditions (the second grade) and fed with
water and rodent chow ad libitum.
Detection of Laboratory Parameters
The serum samples were collected 1 day before administration
and at 10 days after administration from the tail in all three
groups. Fasting blood glucose (FBG) was determined by
methods of glucose oxidase: FBG (mmol l
 1) ¼ assay tube
absorbance/standard tube absorbance 5.55. Fasting insulin
(FINS, mUm l
 1) was measured under the instructions of the
reagent box. Whole blood viscosity at low and high shear rates
(LS, HS), plasma viscosity, hematocrit (HCT) in the blood,
gathering of blood index test (GIT) and fibrinogen (FIB) in
plasma were tested for hemorheology. Insulin-like growth
factor II (IFG-II, ng ml
 1) was measured using the instructions
on the reagent box. Insulin resistance index (Homa-IR) and
insulin secretion index (Homa-IS) were detected by HOMA to
evaluate insulin resistance and beta-cell secretion. Homa-IR ¼
FINS · FBG/22.5; Homa-IS ¼ FINS · 20 (FBG 3.5) (11–14).
Statistical Analysis
Statistical analysis was done with 4Steps Excel (Statcel2)
software. The data are presented as the mean ± standard
deviation. Statistical significance was determined using
analysis of variance, ANOVA and Fisher’s PSLD.
Results
FBG Decreased Significantly in the YYJT Group
The levels of FBG in the YYJT and experimental groups were
significantly elevated (P < 0.001) compared to the control
group after the model was established, but no significant
difference was noted between the experimental and YYJT
groups. At 10 days after administration, the level of FBG in the
YYJT group significantly decreased (P < 0.005) but was still
higher than that in the control group (P < 0.01). There was no
change of FBG in the control and experimental groups
(Fig. 1A).
After establishing the model, the levels of FINS in the YYJT
and experimental groups were significantly lower than in the
control group (P < 0.05), but no significant difference was
noted in the former two groups. No difference was marked
before administration or 10 days after in all three groups
(Fig. 1B).
Homa-IR Decreased, Homa-IS Increased Significantly
in the YYJT Group
The levels of Homa-IR in the YYJT and experimental groups
were significantly increased (P < 0.001) compared to the
control group after the model was established, but no
significant difference was noted between the experimental
and YYJT groups. This suggests that insulin resistance
occurred in the DM rats. Ten days after administration, the
level of Homa-IR in the YYJT group significantly decreased
(P < 0.005), but it was still higher than that in the control
group (P < 0.01). There was no change of Homa-IR in the
control and experimental groups (Fig. 2A).
The levels of Homa-IS in the YYJT and experimental groups
were significantly lower than those in the control group after
the model was established (P < 0.05), but no significant
difference was noted in the former two groups. This might
indicate that beta-cell destruction developed in the DM rats.
The level of Homa-IS significantly increased (P < 0.05) in the
YYJT group administration, but it was still lower than that in
the control group (P < 0.005). No changes of Homa-IS
occurred before administration or 10 days after in the control
or experimental groups (Fig. 2B).
Most of Hemorheologic Parameters Decreased
Significantly in the YYJT Group
The post-administration parameters in the experimental group
largely increased in comparison with those in the control group
(P < 0.05), showing that distinct hemorheologic obstruction
204 Nourishing Yin and promoting blood circulation in TCMoccurred in the DM rats. Compared to the experimental
group, LS, HS, GIT and FIB decreased significantly in
the YYJT group (P < 0.05) at 10 days administered,
while plasma viscosity and HCT were stable (P > 0.05,
Table 1).
Table 2 illustrates the relationship between Homa-IR and
hemorheologic parameters before administration and 10 days
after. The statistically analyzed results explained that Homa-
IR had a correlation with LS and GIT (r ¼ 0.56, 0.88, P <
0.05) after administration. There was no marked relationship
in the other groups.
IFG-II Increased Significantly in the YYJT Group
Compared with the control group, IFG-II declined signifi-
cantly in the DM rats (P < 0.05) and had a negative
relationship to HCT (r ¼  0.69). No difference was noted in
the experimental and YYJT groups. After administration, IFG-
II increased significantly (P < 0.05) in YYJT group while no
changes happened in the other two groups (Fig. 3).
Discussion
In this study, we observed the effects of simple traditional
YYJT preparation on FBG, FINS, hemorheology and IGF-II.
YYJT preparation (troche) consists of milk vetch, dangshen,
Chinese wolfberry fruit, chuanxiong, root of kudzuvine, root
of zhejiang figwort and rehmannia. All these components can
reinforce Qi, nourish Yin, remove blood gore and promote
blood circulation. YYJT is available on the market. The results
of this study proved YYJT to be functional in reducing
glucose, ameliorating insulin resistance, accelerating beta-cell
secretion, downregulating whole blood viscosity at low and
high shear rates, GIT and FIB, and upregulating IFG-II.
Over 90% of all DM cases are diagnosed as type 2, caused
mostly by insulin resistance and beta-cell destruction. WHO
illustrated the onset mechanism of type 2 insulin resistance
with insulin hyposecretion and insulin hyposecretion with or
without insulin resistance (15,16). Gerich (17), however,
considered that beta-cell destruction occurred before insulin
resistance in nosogenesis of type 2 DM. In this study, DM





































Figure 1. Levels of FPG and FINS in the three treatment groups. Picture (A) shows the changes of FPG levels. Picture (B) shows the changes of FINS levels.

























Normal control Model YYJT Normal control Model YYJT
A. B. before administration
After administration
Figure 2. Levels of Homa-IR and Homa-IS in the three treatment groups. Picture (A) shows the changes of Homa-IR levels. Picture (B) shows the changes of
Homa-IS levels. *P-value <0.05. Homa-IR, Homa insulin resistance; Homa-IS, insulin secretion index.
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hyperglycosemia. The hyperglycosemia further destroyed
insulin function and then insulin resistance formed, leading
to worse beta-cell function. Thus, a vicious circle began. All
DM rats in this study followed the above onset mechanism of
type 2 diabetes mellitus and then were treated with YYJT.
Later, their glucose and Homa-IR significantly decreased and
beta-cell secretion was improved. Thismay indicate that YYJT
can decrease glucose in association with promoting beta-cell
function and improving insulin resistance.
Hemorheologic disorder is the outcome of interaction in
the metabolism disorders of glucose, lipid and protein in DM,
which accelerates the combined vasculopathy after DM
(18–21). The hemorheologic disorder in DM patients is
 20% higher than that in non-DM patients. The hemorheolo-
gic parameters vary in different types and clinical phases
of DM, displaying aggregation of erythrocyte and decrease of
erythrocyte deformability (22), especially whole blood
viscosity at low and high shear rates and HCT. The increase
of FIB causes ropier plasma viscosity (23,24). In TCM theory,
DM is in the concept of ‘xiao-ke’ with deficiency of Yin and
dryness-heat, where the in vivo blocks of blood gore leads to
hemorheologic disorder. Such hemokinetic disturbance is
defined as pathological changes in TCM. In this study, the
hemorheologic parameters were much higher in DM rats than
those in the control group before administration, which
expressed DM rats had hemokinetic pathological changes.
After YYJT administration, the whole blood viscosity at low
and high shear rates, GIT and FIB significantly decreased. This
might indicate that YYJT could improve hemorheologic
disorder through removing blood gore and promoting blood
circulation. Insulin resistance is the main factor of secondary
angiopathy (25). To discuss the correlation between hemor-
heology and insulin resistance, we analyzed the relationship of
Homa-IR and blood viscosity index. The outcome showed that
there was a correlation between Homa-IR and whole blood
viscosity at low and high shear rates and GIT, which suggest
that the pharmaceutical effect of promoting blood circulation
and removing blood stasis of YYJT could regulate insulin
resistance to alleviate blood viscosity.
Insulin-like growth factor (IGF) is a polypeptide, classified
into IFG-I and IFG-II. It adjusts the proliferation and
differentiation of cells with insulin-like metabolism and nutri-
tion (26). The beta-cells in the pancreas of humans and rats
contains IFG-II and the alpha-cells contain IFG-I (27). The
gene of IFG-II from man and rodents and the gene of insulin
are homogenous (28), which signifies that IFG-II plays an
important role in beta-cell self-secretion and regulation. We
monitored IFG-II during the study, which decreased in DM
rats and was negatively related with HCT, indicating its close
relation with beta-cell function and blood viscosity. After
YYJT administration, the level of IFG-II increased. We
assumed that YYJT might promote the secretion of IFG-II to
repair or regulate the damaged beta-cells, the exact mechanism
however is still unclear and needs further study.
Conclusions
In this study, we showed that traditional medicine with Yin
nourishing and promoting blood circulation function can
decrease glucose, develop beta-cell function and correct
hemorheologic disorder to positively prevent and treat chronic
complications of DM in DM rat models, but the long-term
efficiency and mechanism is uncertain.
Table 1. Data in hemorheology after administration in rats (X ± S)
N LS (mpa s) HS (mpa s) PV (mpa s) HCT (%) GIT index FIB (g l
 1)
Normal control 12 10.51 ± 1.89 6.11 ± 0.83 1.46 ± 0.17 48.20 ± 5.55 1.20 ± 0.14 2.29 ± 0.59
Model 12 15.61 ± 1.77
D 7.83 ± 0.97
D 1.83 ± 0.19
D 54.30 ± 5.55
D 1.68 ± 0.11
D 4.34 ± 0.75
D
YYJT 12 10.35 ± 1.57* 6.82 ± 0.52
# 1.89 ± 0.19 53.82 ± 6.32 1.32 ± 0.15* 2.53 ± 0.65*
Homa-IR, Homa insulin resistance; LS, low shear rate; HS, high shear rate; PV, plasma viscosity; HCT, hematocrit; GIT, gathering of index test; FIB, fibrinogen.
DP-value <0.01 compared with normal control group; *P-value <0.001 compared with model group;
#P-value <0.05 compared with model group.
Table 2. .Correlation between Homa-IR and hemorheology
Time LS (mpa s) HS (mpa s) GIT index FIB (g l
 1)
Normal control Before 0.2505 0.2463 0.3276  0.1318
After 0.2053 0.0778 0.3226 0.1961
Model Before 0.2935 0.2599 0.2694 0.1432
After 0.3041 0.0466 0.1932 0.1781
YYJT Before 0.3063 0.1394 0.1412 0.1532
After 0.5591* 0.2471 0.8797
D 0.3009
Homa-IR, Homa insulin resistance; LS, low shear rate; HS, high shear rate;
GIT, gathering of index test; FIB, fibrinogen.
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Figure 3. Levels of IGF-II in the three study groups. *P-value <0.05.
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